Skip to main content
Clinical Trials/NCT05371106
NCT05371106RecruitingNot Applicable

Maternal and Newborn Exposure to Mycotoxins in Israel and the Association to Baby's Development in First Months of Life

Assaf-Harofeh Medical Center1 site in 1 country150 target enrollmentStarted: September 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
150
Locations
1
Primary Endpoint
Mycotoxins in breastmilk

Study Overview

Brief Summary

Some plant pathogen fungi may develop in grains, nuts and dry foodstuff during their storage. They secrete toxins which are very resistant and persistent.

The toxins enter the human body through the food. Women eating without their knowledge spoiled food absorb the toxin which is conveyed into their milk. In the same way, meat and dairy products can be contaminated with mycotoxins.

Toxins and their metabolites can have negative effects on pregnant women and on the fetus or infant health.

The main purpose of this trial is to assess the presence of toxins in mothers's milk.

Detailed Description

Fungi from the genus Aspergillus, Penicillium, Fusarium and Alternaria can synthesize toxins. These may be carcinogenic, immunotoxic or endocrine disruptors.

In this trial, Zearalenone, Deoxynivalenol, T-2 toxin, Fumonisin B1, Fumonisin B2, Aflatoxin M1, Aflatoxin B1, Aflatoxin B2, Aflatoxin G1, Aflatoxin G2, Ochratoxin A, HT-2 toxin, De-epoxy-deoxynivalanol presence and quantity will be assessed in mother's milk.

Another purpose is to try to pinpoint at the source(s) of contamination.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Women aged 18 and above.
  • Pregnant women after week 37 intending to breastfeed.
  • Women breastfeeding.

Exclusion Criteria

  • Women taking drugs which influence milk production.
  • Women taking drugs contraindicated during breastfeeding.
  • Women not staying in Israel during third trimester or in the months after birth for a long period of time.
  • Women not wanting/able to fill up the questionnaires.

Outcomes

Primary Outcomes

Mycotoxins in breastmilk

Time Frame: approx. 6 months after recruitment

To measure mycotoxins and mycotoxins metabolites levels in breast milk

Secondary Outcomes

  • Source of contamination(approx. one year after recruitment)

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Mycotoxins in Mothers Milk in Israel | Clinical Trial